ScholarIQanswers from OpenAlex

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma

PaperCitations, authors & open-access status

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma have?

ScholarIQcitation count

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma has 31 citations in the OpenAlex counts ScholarIQ stores.

When was Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma published?

ScholarIQyear

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma has 2022 year in the ScholarIQ index.

What is the open-access status of Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma?

ScholarIQoa status

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma has gold oa status in the ScholarIQ index.

What is the DOI of Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma?

ScholarIQdoi

The DOI for Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma is on the source record.

What is the PMID of Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma?

ScholarIQpmid

The PMID for Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma is on the source record.

What is the OpenAlex record for Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma?

ScholarIQopenalex

The OpenAlex for Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial